Povidone-iodine to stop Access related Infections and Transmission of Staphylococcus aureus (PAINTS)

Brief description of study

Evaluating the impact of regular application of nasal povidone-iodine pre dialysis treatment on reducing rates of S. aureus ARBSI among hemodialysis patients.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Staphylococcus aureus
Age: Between 18 Years - 99 Years
Gender: All

Receiving outpatient chronic hemodialysis, Male or Female, Age 18 or older,

Updated on 09 Mar 2024. Study ID: 834837

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).